Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Goodrx Holdings Inc Cl A (NQ: GDRX )

5.970 +0.030 (+0.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Goodrx Holdings Inc Cl A

< Previous 1 2 3 4 5 6 7 8 Next >
Why GoodRx Is the Antidote to High Drug Prices
This disruptor is making it easy for consumers to find their prescriptions for the cheapest price. 
Via The Motley Fool
3 Healthcare Stocks I Fully Expect to Double or More Within the Next 5 Years
Given time, these companies might do a lot better than that. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021
Upgrades For GoodRx Holdings Inc (NASDAQ:GDRX),... 
Via Benzinga
2 Overpriced Stocks That Investors Should Avoid
Although these companies are coming off strong quarterly results, I still wouldn't invest in them. 
Via The Motley Fool
Unusual Options Activity Insight: GoodRx Holdings
Shares of GoodRx Holdings (NASDAQ:GDRX) saw some unusual o... 
Via Benzinga
Unusual Options Activity Insight: GoodRx Holdings
Shares of GoodRx Holdings (NASDAQ:GDRX) saw some unusual ... 
Via Benzinga
Analyzing GoodRx Holdings's Unusual Options Activity
On Friday, shares of GoodRx Holdings (NASDAQ:GDRX) saw un... 
Via Benzinga
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
GoodRx Holdings, Inc. (GDRX) Q2 2021 Earnings Call Transcript
GDRX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why GoodRx Holdings Trounced the Market Today
The discount-medications specialist looks set to benefit from a return to the doctor's office for many customers. 
Via The Motley Fool
Topics Supply Chain
Exposures Supply Chain
This Week's Earnings Repertoire
With over 87% of S&P 500 companies already having beaten revenue and profit expectations, we're in for another round of Q2 corporate earnings, along with key jobs and... 
Via Benzinga
Topics Stocks
Exposures US Equities
These 2 Healthcare Innovators Might Soon Face a Reckoning
The regulatory environment could shift beneath their feet in the near future. 
Via The Motley Fool
Elon Musk Is Highest Paid CEO For Third Year In A Row: Here Are The Top 10
Elon Musk, who is credited with founding and running Tesla Inc (NASDAQ: TSLA), the leader in the global electric vehicle market, takes the top honors in corporate... 
Via Benzinga
Topics Electric Vehicles
Exposures Electric Vehicles
Why Shares of GoodRx Fell 10.7% in the First Half of 2021
Slowing user growth and the long shadow of a competitor dampened enthusiasm for the stock. 
Via The Motley Fool
Analyzing GoodRx Holdings's Unusual Options Activity
On Friday, shares of GoodRx Holdings (NASDAQ:GDRX) saw unusual options activity. After the option alert, the stock price moved down to $29.45. Sentiment: BEARISH Option Type:... 
Via Benzinga
GoodRx, DoorDash Partner To Offer US Dashers With Subsidized Healthcare Facilities
Healthcare savings resource GoodRx Holdings Inc (NASDAQ: GDRX) collaborated with online food ordering and delivery platform DoorDash Inc (NYSE: DASH... 
Via Benzinga
Analyzing GoodRx Holdings's Unusual Options Activity
GoodRx Holdings (NASDAQ:GDRX) shares experienced unusual options activity on Thursday. The stock price moved up to $33 following the option alert. Sentiment: BULLISH Option Type... 
Via Benzinga
How Will GoodRx Fare Against Competition?
It has several key advantages. 
Via The Motley Fool
With Prices Going Up, Consumers Will Flock to This Healthcare Tech Specialist
The one metric for investors to watch. 
Via The Motley Fool
Jim Cramer Gives His Opinion On SoFi, GoodRx And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said "he is a buyer of Anthony Noto," the CEO of SoFi Technologies Inc (NASDAQ: SOFI). They have been... 
Via Benzinga
3 Great Candidates to Be the Summer's Hottest Meme Stocks
They're beaten down. Short-sellers have piled on. In other words, they're ideal meme stocks. 
Via The Motley Fool
Move Over, AMC: Here's a Short Squeeze Candidate With as Much Cash and a Brighter Future
The metrics for this digital healthcare platform are headed higher for the right reasons. 
Via The Motley Fool
Is GoodRx the Prescription for Your Portfolio?
You're probably paying too much for your drugs. Fortunately, there's some help on the way. 
Via The Motley Fool
Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, And More
Some return buyers were among the insiders acquiring shares this last week. A beauty products company and an online dating outfit were among the firms that saw notable insider buying. 
Via Talk Markets
Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, More
Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near all-time highs. Some return buyers were among the insiders... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 28, 2021
Upgrades For Delek US Holdings Inc (NYSE:DK), Tudor Pickering upgraded the previous rating of Hold to Buy. For the first quarter, Delek US Hldgs had an EPS of $1.69,... 
Via Benzinga
Here's the Top Takeaway for Healthcare Investors Right Now
There are just three words to remember. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Notable Insider Buys Of The Past Week: AT&T, GoodRx, Opendoor Technologies, And More
A couple of chief executive officers and a president were among the insiders buying shares this past week. A leading telecom that just announced a major deal was among companies that saw notable... 
Via Talk Markets
Notable Insider Buys Of The Past Week: AT&T, GoodRx, Opendoor Technologies And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A couple of chief executive officers and a president were... 
Via Benzinga
Is Now the Time to Buy This Pharma Industry Disruptor?
This consumer healthcare platform went public last fall and is looking to shake up a big part of the healthcare industry. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.